Skip to main content

Advertisement

SpringerLink
Log in

The Italian Horizon Scanning Project

  • Special Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Stevens A, Milne R, Lilford R, Gabbay J (1999) How do new technologies get into practice? Keeping pace with new technologies: systems needed to identify and evaluate them. Br Med J 319:1291–1294

    CAS  Google Scholar 

  2. http://www.phrma.org/files/2008%20Profile.pdf. Accessed December 2008

  3. Joppi R, Bertele' V, Garattini S (2005) Disappointing biotech. Br Med J 331:895–897

    Article  Google Scholar 

  4. Bertele' V, Banzi R, Capasso F, Tafuri G, Trotta F, Apolone G, Garattini S (2007) Haematological anticancer drugs in Europe: any added value at the time of approval? Eur J Clin Pharmacol 63(7):713–719

    Article  PubMed  Google Scholar 

  5. Garattini S, Bertele’ V (2007) How can we regulate medicines better? Br Med J 335(7624):803–805

    Article  Google Scholar 

  6. Banta HD (1997) Introduction to the EUR-ASSESS report. Int J Technol Assess Health Care 13:133–143

    Article  Google Scholar 

  7. Hailey D, Topfer LA, Willis F (2001) Providing information on emerging health technologies to provincial decision makers: a pilot project. Health Policy 58(1):15–26

    Article  PubMed  CAS  Google Scholar 

  8. Packer C (2005) The National Horizon Scanning Centre (NHSC): early warning for new and emerging health technologies in England. Evidence-Based Healthcare & Public Health 9:410–413

    Article  Google Scholar 

  9. http://www.euroscan.bham.ac.uk. Accessed 10 Feb 2009

  10. http://horizon.cineca.it/

  11. Motola D, De Ponti F, Rossi P, Martini N, Montanaro N (2005) Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. Br J Clin Pharmacol 59(4):475–478

    Article  PubMed  Google Scholar 

  12. Motola D, De Ponti F, Poluzzi E, Martini N, Rossi P, Silvani MC, Vaccheri A, Montanaro N (2006) An update on the first decade of the European centralized procedure: how many innovative drugs? Br J Clin Pharmacol 62(5):610–616

    Article  PubMed  Google Scholar 

  13. Noorani HZ, Huserau DR, Boudreau R (2007) Priority setting for health technology assessments: a systematic review of current practical approaches. Int J Technol Assess Health Care 23(3):310–315

    Article  PubMed  Google Scholar 

  14. Murphy K, Packer C, Stevens A, Simpson S (2007) Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systems. Int J Technol Assess Health Care 23(3):324–330

    Article  PubMed  Google Scholar 

  15. Wiviott SD et al (2007) Prasugrel versus clopidogrel in patients with Acute Coronary Syndromes. N Engl J Med 357(20):2001–2015

    Article  PubMed  CAS  Google Scholar 

  16. Wiviott SD et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel thrombolysis in myocardial infarction 38. Circulation 118:1626–1636

    Article  PubMed  CAS  Google Scholar 

  17. http://sanita.cineca.it/public/arno/arnoeng.htm. Accessed 10 Feb 2009

  18. Gershlick AH, Richardson G (2006) Drug eluting stents: dual antiplatelet therapy should not be discontinued without referral to a cardiologist. Br Med J 333:1233–1234

    Article  CAS  Google Scholar 

  19. Bhatt DL (2009) Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Am J Cardiol 103[Suppl 3]:11A–19A

    Article  PubMed  CAS  Google Scholar 

  20. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 9:e191. doi:10.1371/journal.pmed.0050191

  21. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 11:e217. doi:10.1371/journal.pmed.0050217

  22. http://www.fda.gov/oc/initiatives/advance/fdaaa.html. Accessed 10 Feb 2009

  23. Konstam MA, Gheorghiade M, Burnett JC Jr et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297(12):1319–1331

    Article  PubMed  CAS  Google Scholar 

  24. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, for the SALT investigators (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Judith Baggott and Ruth Davis for editorial assistance.

Funding

Institutional funds from the Local Health Unit of Verona, the Veneto Region and the Italian Medicines Agency

Conflict of interest

None

Author information

Authors and Affiliations

  1. Pharmaceutical Department, Local Health Unit of Verona, Via Salvo D’Acquisto 7, 37122, Verona, Italy

    Roberta Joppi, Anna Michela Menti, Daniela Pase, Chiara Poggiani & Luigi Mezzalira

  2. CINECA–Consortium of Universities, Via Magnanelli 6/3, 40033, Casalecchio di Reno, BO, Italy

    Luca Demattè

Authors
  1. Roberta Joppi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Demattè
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Michela Menti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniela Pase
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chiara Poggiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luigi Mezzalira
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Italian Horizon Scanning Project Group

Corresponding author

Correspondence to Roberta Joppi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joppi, R., Demattè, L., Menti, A.M. et al. The Italian Horizon Scanning Project. Eur J Clin Pharmacol 65, 775–781 (2009). https://doi.org/10.1007/s00228-009-0666-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0666-z

Keywords

Search

Navigation